Race Oncology Limited (RAC.AX)
AUD 1.18
(-2.89%)
AUD 1.18
(-2.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -17.18 Million AUD | -795.08% |
| 2023 | -1.92 Million AUD | 68.21% |
| 2022 | -6.04 Million AUD | 35.2% |
| 2021 | -9.32 Million AUD | -438.63% |
| 2020 | -1.73 Million AUD | -75.05% |
| 2019 | -988.71 Thousand AUD | 73.35% |
| 2018 | -3.7 Million AUD | -118.64% |
| 2017 | -1.69 Million AUD | 60.94% |
| 2016 | -4.34 Million AUD | -20306.31% |
| 2015 | -21.28 Thousand AUD | 55.91% |
| 2014 | -48.27 Thousand AUD | 53.66% |
| 2013 | -104.19 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -1.38 Million AUD | 27.68% |
| 2024 Q2 | -13.71 Million AUD | 0.0% |
| 2024 Q4 | -17.18 Million AUD | 0.0% |
| 2023 Q2 | -26.37 Million AUD | 0.0% |
| 2023 Q4 | -1.92 Million AUD | 0.0% |
| 2023 FY | -1.92 Million AUD | 68.21% |
| 2022 Q4 | -6.04 Million AUD | 0.0% |
| 2022 Q2 | -37.1 Million AUD | 0.0% |
| 2022 FY | -6.04 Million AUD | 35.2% |
| 2021 Q2 | -5.57 Million AUD | 0.0% |
| 2021 Q4 | -9.32 Million AUD | 0.0% |
| 2021 FY | -9.32 Million AUD | -438.63% |
| 2020 Q2 | -1.54 Million AUD | 0.0% |
| 2020 FY | -1.73 Million AUD | -75.05% |
| 2020 Q4 | -1.73 Million AUD | 0.0% |
| 2019 FY | -988.71 Thousand AUD | 73.35% |
| 2019 Q4 | -988.71 Thousand AUD | 0.0% |
| 2019 Q2 | -2.07 Million AUD | 0.0% |
| 2018 FY | -3.7 Million AUD | -118.64% |
| 2018 Q2 | -1.63 Million AUD | 0.0% |
| 2018 Q4 | -3.7 Million AUD | 0.0% |
| 2017 Q4 | -1.69 Million AUD | 0.0% |
| 2017 FY | -1.69 Million AUD | 60.94% |
| 2017 Q2 | -3.04 Million AUD | 0.0% |
| 2016 FY | -4.34 Million AUD | -20306.31% |
| 2016 Q4 | -4.34 Million AUD | 0.0% |
| 2016 Q2 | -827.00 AUD | 0.0% |
| 2015 FY | -21.28 Thousand AUD | 55.91% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q3 | -21.28 Thousand AUD | 0.0% |
| 2015 Q4 | -21.28 Thousand AUD | 0.0% |
| 2014 FY | -48.27 Thousand AUD | 53.66% |
| 2013 FY | -104.19 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -1933.764% |
| Acrux Limited | -1.45 Million AUD | -1078.932% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -842.581% |
| Biome Australia Limited | -1.56 Million AUD | -999.869% |
| BTC Health Limited | -2.02 Million AUD | -750.025% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -463.014% |
| CSL Limited | 15.76 Billion AUD | 100.109% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 87.408% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 90.607% |
| Noxopharm Limited | -2.31 Million AUD | -640.921% |
| PharmAust Limited | -9.71 Million AUD | -76.947% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -171.81% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -69.136% |
| PYC Therapeutics Limited | -65.76 Million AUD | 73.862% |
| Starpharma Holdings Limited | -19.83 Million AUD | 13.328% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 9.048% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 78.327% |
| Memphasys Limited | 4.13 Million AUD | 515.654% |
| Nyrada Inc. | -4.76 Million AUD | -260.4% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1650.199% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 83.752% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2322.47% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 439.209% |
| Patrys Limited | -2.24 Million AUD | -667.132% |
| Dimerix Limited | -21.99 Million AUD | 21.84% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -0.555% |
| Orthocell Limited | -19.92 Million AUD | 13.731% |
| Imugene Limited | -91.56 Million AUD | 81.227% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -176.997% |
| Immutep Limited | -122.18 Million AUD | 85.933% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -35.192% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -37.733% |
| Nanollose Limited | -96.22 Thousand AUD | -17763.161% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -185.289% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -246.959% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1287.977% |
| Biotron Limited | -386.06 Thousand AUD | -4352.28% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 7.463% |
| Tissue Repair Ltd | -16.44 Million AUD | -4.548% |
| AnteoTech Limited | -5 Million AUD | -243.672% |
| Hexima Limited | -2.22 Million AUD | -672.11% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 2.233% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -406.129% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -222.538% |
| Actinogen Medical Limited | -9.13 Million AUD | -88.233% |
| Immuron Limited | -11.48 Million AUD | -49.679% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -8.02% |